文献速递神经肿瘤

米非司酮通过PR/p53/HO1/GPX4轴在脑膜瘤细胞中实现肿瘤抑制与铁死亡

Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells.
PubMed 文献 · J Neurooncol · 2025-01-03

本研究探讨米非司酮对恶性和良性脑膜瘤细胞增殖、运动与侵袭的影响,并识别敏感类型及分子机制。IOMM-Lee和HBL-52细胞经米非司酮处理后,增殖、运动与侵袭呈剂量和时间依赖性抑制。RNA测序显示铁死亡通路基因上调,p53和HO1表达增加、GPX4表达减少,伴脂质过氧化、Fe2+蓄积和ROS释放。结论认为米非司酮经PR/p53/HO1/GPX4轴诱导脑膜瘤细胞铁死亡,提示其可能用于铁死亡敏感型脑膜瘤的治疗。

要点

  • 米非司酮剂量和时间依赖性抑制IOMM-Lee和HBL-52脑膜瘤细胞的增殖、运动与侵袭。
  • 两株细胞中铁死亡通路基因显著富集,p53和HO1表达升高、GPX4表达降低。
  • 米非司酮相关孕激素受体表达相应降低,提示经PR/p53/HO1/GPX4轴诱导铁死亡。

核心结论

  • 米非司酮经PR/p53/HO1/GPX4轴诱导脑膜瘤细胞铁死亡,提示其可能作为铁死亡敏感型脑膜瘤的治疗手段。

研究设计与样本

  • 体外细胞实验:IOMM-Lee和HBL-52脑膜瘤细胞分别以0、溶剂对照、5、10、20、40、80 μM米非司酮处理12、24、48、72、96 h。

主要发现

  • 米非司酮剂量和时间依赖性抑制IOMM-Lee和HBL-52细胞的增殖、运动与侵袭。
  • RNA测序显示两株细胞中上调基因显著富集于铁死亡通路,并被p53和HO1表达升高、GPX4表达降低、脂质过氧化、Fe2+蓄积和ROS释放所证实。
  • 免疫荧光染色和RT-PCR显示米非司酮相关孕激素受体表达相应降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study explores the effects of mifepristone on the proliferation, motility, and invasion of malignant and benign meningioma cells, aiming to identify mifepristone-sensitive types and investigate the underlying molecular mechanisms. METHODS: IOMM-Lee and HBL-52 meningioma cells were treated with 0, vehicle control (VC), 5, 10, 20, 40, and 80 μM of mifepristone for 12, 24, 48, 72, and 96 h. Proliferation was assessed via CCK8 assay, while motility and invasion were measured using wound scratch and transwell assays. RNA sequencing and RT-PCR were used to analyze gene expression changes. RESULTS: Mifepristone inhibited proliferation, motility, and invasion in both IOMM-Lee and HBL-52 cells in a dose- and time-dependent manner. RNA sequencing showed up-regulated genes significantly enriched in the ferroptosis pathway in both cell lines, confirmed by increased p53 and HO1 expression, decreased GPX4 expression, lipid peroxidation, Fe2+ accumulation, and ROS release. Immunofluorescence staining and RT-PCR also revealed a corresponding decrease in mifepristone-related progesterone receptor expression. CONCLUSION: Mifepristone induces ferroptosis in meningioma cells via the PR/p53/HO1/GPX4 axis, suggesting its potential as a treatment for ferroptosis-sensitive meningiomas. It also supplies new clues regarding ferroptosis as a treatment entry point for meningiomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Dai Q, Wei J, Li Z, et al. Mifepristone achieves tumor suppression and ferroptosis through PR/p53/HO1/GPX4 axis in meningioma cells. J Neurooncol. 2025. PMID: 39751705. doi:10.1007/s11060-024-04918-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。